4.7 Article

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error

Hyunwoo Lee et al.

Summary: This study analyzed the detection of TERT mutations in glioblastomas using targeted next-generation sequencing (NGS) and compared the results with Sanger sequencing. The study found that targeted NGS failed to detect any TERT mutations, which were detected by Sanger sequencing. Manual visualization of the NGS data revealed false-negative results due to very low read depth. Optimization of the customized panel improved the amplification of the TERT promoter region.

CANCER RESEARCH AND TREATMENT (2022)

Article Multidisciplinary Sciences

Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hurthle cell carcinoma

Ian Ganly et al.

Summary: This study analyzed genomic, metabolomic, and immunophenotypic data of HCC and other thyroid cancers. The results showed that HCC and other thyroid malignancies commonly exhibit mtDNA mutations and depletion of citrate pools, while HCC specifically has elevated metabolites in the reduced form of NADH-dependent lysine degradation pathway. The presence of gLOH is associated with reduced immune infiltration. Additionally, unsupervised clustering identified four clusters of HCC with distinct clinical, metabolomic, and microenvironmental phenotypes.

SCIENCE ADVANCES (2022)

Article Medicine, General & Internal

Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens

Guodong Fu et al.

Summary: This diagnostic study developed a sensitive molecular assay for detection and quantification of BRAF V600E variation in residual tissue from thyroid FNA biopsies to identify patients with cancer harboring BRAF V600E in a cost-effective manner, highlighting the clinical value of molecular assay of the remaining FNA tissue in the management of thyroid nodules.

JAMA NETWORK OPEN (2021)

Article Oncology

Diagnostic Value of Galectin-3 in Distinguishing Invasive Encapsulated Carcinoma from Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features (NIFTP)

Guodong Fu et al.

Summary: The research suggests that increased cytoplasmic Gal-3 expression has diagnostic potential in distinguishing NIFTP among encapsulated follicular variant nodules, serving as a possible ancillary test to assist in the detection of invasive EFVPTC when LT interference is absent.

CANCERS (2021)

Article Medicine, General & Internal

The Role of Cytology in the Diagnosis of Subcentimeter Thyroid Lesions

Vincenzo Fiorentino et al.

Summary: This study found that 57.2% of suspected subcentimeter thyroid nodules were malignant, with a small proportion belonging to indeterminate categories. Aspirates of subcentimeter lesions yielded satisfactory results, with very few non-diagnostic samples. Suspected ultrasound features in subcentimeter lesions should be evaluated and followed up by an interdisciplinary team for appropriate patient management.

DIAGNOSTICS (2021)

Article Endocrinology & Metabolism

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules

Preethi Polavarapu et al.

Summary: This study retrospectively analyzed cytologically indeterminate thyroid nodules and found that the implementation of the Afirma Gene Expression Classifier (GEC) did not affect surgical or malignancy rates, while the Genomic Sequencing Classifier (GSC) resulted in significantly lower surgical rates and higher malignancy rates. Factors associated with the decision to undergo molecular testing were identified, providing insights into the real-world use of molecular markers in indeterminate thyroid nodules.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Article Multidisciplinary Sciences

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Esther Rheinbay et al.

NATURE (2020)

Review Cell Biology

The Solo Play of TERT Promoter Mutations

Francois Hafezi et al.

Review Otorhinolaryngology

Molecular Profiling of Thyroid Nodules-Are These Findings Meaningful, or Merely Measurable? A Review

Luc G. T. Morris

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Article Biochemistry & Molecular Biology

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

Pedram Razavi et al.

NATURE MEDICINE (2019)

Article Oncology

Untitled

CANCER (2018)

Article Oncology

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours

Johan O. Paulsson et al.

ENDOCRINE-RELATED CANCER (2018)

Article Medicine, General & Internal

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

Hyeyeun Lim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Biochemistry & Molecular Biology

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir et al.

NATURE MEDICINE (2017)

Review Oncology

TERT promoter mutations in thyroid cancer

Rengyun Liu et al.

ENDOCRINE-RELATED CANCER (2016)

Review Endocrinology & Metabolism

Systematic Review of Trends in the Incidence Rates of Thyroid Cancer

Joseph J. Wiltshire et al.

THYROID (2016)

Article Multidisciplinary Sciences

TERT promoter mutations and telomerase reactivation in urothelial cancer

Sumit Borah et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal et al.

Article Multidisciplinary Sciences

Discovery and saturation analysis of cancer genes across 21 tumour types

Michael S. Lawrence et al.

NATURE (2014)

Article Multidisciplinary Sciences

Mutational landscape and significance across 12 major cancer types

Cyriac Kandoth et al.

NATURE (2013)

Article Multidisciplinary Sciences

TERT Promoter Mutations in Familial and Sporadic Melanoma

Susanne Horn et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Highly Recurrent TERT Promoter Mutations in Human Melanoma

Franklin W. Huang et al.

SCIENCE (2013)

Review Multidisciplinary Sciences

Cancer Genome Landscapes

Bert Vogelstein et al.

SCIENCE (2013)

Article Endocrinology & Metabolism

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies

Maria Chiara Zatelli et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)

Article Biochemistry & Molecular Biology

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules

Suk Kyeong Kim et al.

DIAGNOSTIC MOLECULAR PATHOLOGY (2008)

Article Biochemistry & Molecular Biology

Design of LNA probes that improve mismatch discrimination

Yong You et al.

NUCLEIC ACIDS RESEARCH (2006)

Article Oncology

BRAF mutation in papillary thyroid carcinoma

J Cohen et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

Article Multidisciplinary Sciences

Mutations of the BRAF gene in human cancer

H Davies et al.

NATURE (2002)